2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetic acid | CAS:35665-38-4

We serve 2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetic acid CAS:35665-38-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetic acid

Chemical Name:  2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetic acid
CAS.NO: 35665-38-4
Molecular Formula:C19H18N2O5
Molecular Weight:354.35700

Synonyms:
N-9-fluorenylmethoxycarbonyl-glycyl-glycine
Fmoc-Gly-Gly
2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)acetamido)acetic acid
Fmoc-Gly-Gly-OH
Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycyl-
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycine
FMOC-GLYCYL-GLYCINE

Physical and Chemical Properties:
Density: 1.338g / cm3
Boiling point: 684.1ºC at 760 mmHg
Flash point: 367.5ºC
Refractive index: 1.613

Specification:
Appearance:White to off white powder
Purity:≥98%
Loss on drying: ≤1.0%(70 o C, 2h)
Water Content(K.F.):≤1.0%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -15ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.



Contact us for information like 2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,FMOC-GLYCYL-GLYCINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Fmoc-Gly-Gly-OH Use and application,N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycine technical grade,usp/ep/jp grade.


Related News: Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-one manufacturer Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.4-methyl-4-methylsulfanylpentan-2-one supplier Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity.4-[(4-fluoroanilino)methylidene]cyclohexa-2,5-dien-1-one vendor At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity.INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.